Innovative Health Sciences, Inc. (PINKSHEETS: IHSN) announced today that it has restructured its agreement with Harrington Multi Media Marketing (HM3). Under the terms of the new agreement, IHSN will reduce its annual capital commitment costs by more than $500,000.00, while maintaining its participation rights for marketing projects and products for which HM3 developed infomercials. Innovative Health Sciences, Inc. expects to continue to work with HM3 on our existing projects as well as potential projects currently being reviewed. IHSN's goal is to identify new projects that can create a diverse portfolio, while developing the potential for significant upside to generate revenues.

Also, as part of its restructuring plan, and to bolster the capital structure, the Company has elected to cancel and retire certain common shares of its affiliates.

Innovative Health Sciences, Inc. has embraced as its corporate mission, a plan to participate in and acquire interests that are leading edge in their respective market niches, and that have expectations of enhancing shareholder values.

This press release contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934 and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of the Company to be materially different from the statements made herein. Statements contained in this news release, other than those identifying historical facts, constitute "forward-looking statements" within the meaning of Section 21E of the Securities Exchange Act of 1934 and the Safe Harbor provisions as contained in the Private Securities Litigation Reform Act of 1995. Such forward-looking statements relating to the Company's future expectations, including but not limited to revenues and earnings, technology efficacy, strategies and plans, are subject to safe harbors protection. Actual Company results and performance may be materially different from any future results, performance, strategies, plans, or achievements that may be expressed or implied by any such forward-looking statements. The Company disclaims any obligation to update or revise any forward-looking statements.

Contact: Innovative Health Sciences, Inc. Chris Winter President chris@ihs-development.com (770) 753-6448